RecruitingPhase 3NCT04967989

Clarifying the Optimal Application of SLT Therapy Trial

Sponsor

University of Pittsburgh

Enrollment

790 participants

Start Date

Sep 7, 2021

Study Type

INTERVENTIONAL

Conditions

Glaucoma and Ocular Hypertension

Summary

The goal of this study is to understand if SLT performed at low energy is as effective as SLT performed at standard energy, and also to see if repeating SLT at low energy once a year will prevent or delay the need for daily eye drop medications better than waiting for SLT to wear off before repeating it.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a laser eye treatment called Selective Laser Trabeculoplasty (SLT) to find out when and how it works best for people with high eye pressure or glaucoma (a condition where increased eye pressure can damage vision). **You may be eligible if...** - You are 18 years or older and in good health - You have been diagnosed with high eye pressure (ocular hypertension) with pressure over 21 mmHg, OR - You have mild to moderate primary open-angle glaucoma (the most common type), based on your visual field and optic nerve assessment **You may NOT be eligible if...** - You have severe or advanced glaucoma - You have a form of glaucoma other than primary open-angle glaucoma (such as angle-closure, secondary, or congenital glaucoma) - You have had prior laser or surgical treatment for glaucoma in the eye being studied - You have serious eye conditions that would affect results Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURELow Energy SLT

SLT performed at low energy

PROCEDUREStandard Energy SLT

SLT performed at standard energy

Locations(29)

Harvard Eye Associates

Laguna Hills, California, United States

Doheny Eye Center UCLA

Pasadena, California, United States

University of California, Davis

Sacramento, California, United States

University of California, San Francisco

San Francisco, California, United States

Mile High Eye Institute

Sheridan, Colorado, United States

Clear Vue Laser Eye Center

Lakeworth, Florida, United States

Northwestern Medical Group

Chicago, Illinois, United States

Chicago Arbor Eye Institute

Orland Park, Illinois, United States

Illinois Eye Center

Peoria, Illinois, United States

Wilmer Eye Institute Johns Hopkins

Baltimore, Maryland, United States

Massachusetts Eye and Ear

Boston, Massachusetts, United States

Ophthalmic Consultants of Boston

Boston, Massachusetts, United States

Mark Latina, LLC

Reading, Massachusetts, United States

University of Michigan Kellogg Eye Center

Ann Arbor, Michigan, United States

Kresge Eye Institute Wayne State University

Detroit, Michigan, United States

New York Eye Surgery Associates

The Bronx, New York, United States

University Hospitals Eye Institute

Cleveland, Ohio, United States

Cleveland Clinic Cole Eye Institute

Cleveland, Ohio, United States

Devers Eye Institute

Portland, Oregon, United States

Eye Care Specialists

Kingston, Pennsylvania, United States

Scheie Eye Institute

Philadelphia, Pennsylvania, United States

Wills Eye Hospital

Philadelphia, Pennsylvania, United States

UPMC Eye Center

Pittsburgh, Pennsylvania, United States

Vanderbilt Eye Institute

Nashville, Tennessee, United States

Ophthalmology Associates

Fort Worth, Texas, United States

Spokane Eye Clinical Research

Spokane, Washington, United States

West Virginia University

Morgantown, West Virginia, United States

University of Wisconsin-Madison

Madison, Wisconsin, United States

Ocular Health Centre

Kitchener, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04967989

Related Trials

24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring

NCT066896963 locations